; and (B) is registered under the Controlled Substances Act ( 21 U.S.C. 801 et seq.) to engage in such activity with a controlled substance in schedule II in section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812(c) ). (c) Registration for the commercial production and distribution of food and drug administration approved drugs The Attorney General shall register an applicant to manufacture or distribute cannabidiol or marihuana for the purpose of commercial production of a drug containing or derived from marihuana that is approved by the Secretary of Health and Human Services under section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ), in accordance with the applicable requirements under subsection (a) or (b) of section 303 of the Controlled Substances Act ( 21 U.S.C. 823 ). (d) Timely processing of registration applications (1) In general Not later than 60 days after the Attorney General receives an application for registration under the Controlled Substances Act ( 21 U.S.C. 801 et seq.) to manufacture, distribute, dispense, or possess controlled substances, the Attorney General shall— (A) grant or deny the application; or (B) request supplemental information. (2) Additional information Not later than 30 days after the Attorney General receives supplemental information as described in paragraph (1)(B) in connection with an application described in paragraph (1), the Attorney General shall grant or deny the application. (e) Information regarding denials If an application described in subsection (d)(1) is denied, the Attorney General shall provide a written explanation of the basis of denial to the applicant. 6. Importation of cannabidiol for research purposes The Controlled Substances Import and Export Act ( 21 U.S.C. 951 et seq.) is amended— (1) in section 1002(a) ( 21 U.S.C. 952(a) )— (A) in paragraph (1), by striking and at the end; (B) in paragraph (2)(C), by inserting and after uses,